Mylan Is Only Just Beginning Its Biosimilars Journey

Says 2020 Will Be ‘Year Of Expansion’ For Biosimilars Program

 
• By David Wallace
  
White_Trainers_Road
Mylan says its existing biosimilars are just the beginning of its long-term vision for the business • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business